Fu Jiye, Wang Juguang, Jiang Chu, Shi Rujing, Ma Tianwei
Beijing Haidian Center for Disease Control and Prevention, NO.5 Xibeiwang 2nd Road, Haidian district, Beijing 100094, People's Republic of China.
Beijing Haidian Center for Disease Control and Prevention, NO.5 Xibeiwang 2nd Road, Haidian district, Beijing 100094, People's Republic of China.
Int J Infect Dis. 2015 Aug;37:14-8. doi: 10.1016/j.ijid.2015.06.003. Epub 2015 Jun 10.
Varicella vaccine is available for private purchase in Beijing, with single dose recommended for children aged ≥12 months before 2013. Despite the success achieved in reducing varicella incidence, varicella outbreaks continued to occur, including in schools and kindergartens among highly vaccinated children. We investigated a varicella outbreak in a preschool with high varicella vaccination coverage in Haidian district, Beijing.
Through questionnaires, data including children's medical and vaccination history were collected from their parents. A case of varicella was defined as an acute, generalized, maculopapulovesicular rash without other apparent cause in a child in the preschool from March 10 through March 29, 2010. Attack rates in vaccinated and unvaccinated children were calculated, and the analyses of vaccine effectiveness (VE) and of risk factors for breakthrough disease (varicella occurring >42 days after vaccination) were conducted.
A total of 12 cases occurred during the outbreak, and ten of them (83.3%) had breakthrough varicella. The index case with mild varicella occurred in a child who had been vaccinated four years previously. Questionnaires were returned for all of 150 children in the preschool. Of all the 150 children, 144 (96.0%) had no prior history of varicella disease. Among these children, 135(93.7%) had received single-dose varicella vaccine before the outbreak. VE was 84.5% [95% confidence interval (CI): 62.8%∼93.5%] in preventing varicella of any severity, and VE was 92.2% (95% CI: 81.4%∼96.8%) against moderate to severe varicella. Age at vaccination (<15 months vs. ≥15 months) and time since vaccination before the outbreak (<3 years vs. ≥3 years) were not associated with the increased risk of breakthrough varicella(P=0.124 and 1, respectively). All the varicella cases with vaccination history verified through immunization records had received varicella vaccine and measles-mumps-rubella vaccine >30 days apart.
Breakthrough infection with fever in vaccinated person may be as infectious as varicella in unvaccinated persons. High single-dose varicella vaccination coverage is effective in reducing varicella incidence, but not sufficient to prevent outbreak. To control varicella outbreak a second dose may deserve additional consideration.
在北京,水痘疫苗可供个人购买,2013年以前建议≥12月龄儿童接种单剂疫苗。尽管在降低水痘发病率方面取得了成功,但水痘疫情仍持续发生,包括在接种率高的学校和幼儿园。我们调查了北京市海淀区一所水痘疫苗接种率高的幼儿园发生的水痘疫情。
通过问卷调查从家长处收集儿童的病史和疫苗接种史等数据。水痘病例定义为2010年3月10日至3月29日该幼儿园内无其他明显病因的急性、全身性、斑丘疹水疱疹患儿。计算接种疫苗和未接种疫苗儿童的发病率,并分析疫苗效力(VE)和突破性疾病(接种疫苗>42天后发生水痘)的危险因素。
疫情期间共发生12例病例,其中10例(83.3%)为突破性水痘。首例水痘轻症病例发生在一名4年前接种过疫苗的儿童身上。该幼儿园150名儿童的问卷全部回收。150名儿童中,144名(96.0%)既往无水痘病史。在这些儿童中,135名(93.7%)在疫情爆发前接种过单剂水痘疫苗。预防任何严重程度水痘的VE为84.5%[95%置信区间(CI):62.8%~93.5%],预防中度至重度水痘的VE为92.2%(95%CI:81.4%~96.8%)。接种疫苗时的年龄(<15个月与≥15个月)以及疫情爆发前接种疫苗后的时间(<3年与≥3年)与突破性水痘风险增加无关(P分别为0.124和1)。通过免疫记录核实有疫苗接种史的所有水痘病例,水痘疫苗和麻疹-腮腺炎-风疹疫苗接种间隔均>30天。
接种疫苗者发生的突破性感染伴发热可能与未接种疫苗者的水痘传染性一样强。单剂水痘疫苗高接种率可有效降低水痘发病率,但不足以预防疫情爆发。为控制水痘疫情,可能值得考虑接种第二剂疫苗。